Fluocinonide
Brands: Vanos · Fluocinonide
13 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 33 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Brands: Vanos · Fluocinonide
Average across 33 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 10 | SUPPLYING |
| Cosette Pharmaceuticals, Inc. | unknown | 6 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 6 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | generic | 6 | SUPPLYING |
| Encube Ethicals, Inc. | unknown | 4 | SUPPLYING |
| A-S Medication Solutions | repackager | 4 | SUPPLYING |
| Amneal Pharmaceuticals LLC | generic | 4 | SUPPLYING |
| Asclemed USA, Inc. | repackager | 3 | SUPPLYING |
| Zydus Lifesciences Limited | generic | 3 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | generic | 3 | SUPPLYING |
| Viona Pharmaceuticals Inc | unknown | 3 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 3 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 1 | SUPPLYING |
| Bausch Health US, LLC | unknown | 3 | EXITED 2026 |
Shortages, recalls, and registration changes attached to this drug concept.
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA.
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA.
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA.
Cross contamination with other products: traces of Dapsone were found in the finished product. — Recalling firm: Taro Pharmaceuticals U.S.A., Inc. — Nationwide
Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate. — Recalling firm: Taro Pharmaceuticals U.S.A., Inc. — U.S. Nationwide